Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products

Chemoresistance remains a major problem in the treatment of gastric cancer patients. Hence, novel pharmacological agents that can overcome drug resistance are urgently required. Whether simvastatin can sensitize the gastric cancer to the antitumor effects of capecitabine in vitro and in vivo was inv...

Full description

Bibliographic Details
Main Authors: Manu, K., Shanmugam, M., Li, F., Chen, L., Siveen, K., Ahn, K., Kumar, Alan Prem, Sethi, G.
Format: Journal Article
Published: Springer 2013
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/21839
_version_ 1848750702648623104
author Manu, K.
Shanmugam, M.
Li, F.
Chen, L.
Siveen, K.
Ahn, K.
Kumar, Alan Prem
Sethi, G.
author_facet Manu, K.
Shanmugam, M.
Li, F.
Chen, L.
Siveen, K.
Ahn, K.
Kumar, Alan Prem
Sethi, G.
author_sort Manu, K.
building Curtin Institutional Repository
collection Online Access
description Chemoresistance remains a major problem in the treatment of gastric cancer patients. Hence, novel pharmacological agents that can overcome drug resistance are urgently required. Whether simvastatin can sensitize the gastric cancer to the antitumor effects of capecitabine in vitro and in vivo was investigated. The effect of simvastatin on the proliferation of gastric cancer cells was examined by mitochondrial dyeuptake 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method, apoptosis by esterase staining, NF-?B activation by DNA binding assay, and protein expression by western blot analysis. The effect of simvastatin on the tumor growth in xenograft mouse model of human gastric cancer was also examined. Simvastatin suppressed the proliferation of gastric cancer cells, enhanced the apoptotic effects of capecitabine, suppressed the constitutive activation ofNF-?B, and abrogated the expression of cyclooxygenase-2 (COX-2), cyclin D1, Bcl-2, survivin, CXC motif receptor 4, and MMP-9 proteins. In a xenograft mouse model, we observed that the administration of simvastatin alone (5 mg/ kg body weight, intraperitoneal thrice/week) significantly suppressed the growth of the tumor and this effect was further potentiated by capecitabine treatment. As compared to the vehicle control, simvastatin also suppressed the expression of NF-?B-regulated gene products such as cyclin D1, COX- 2, ICAM-1, MMP-9, survivin, Bcl-xL, and XIAP in tumor tissues. Overall, our results demonstrate that simvastatin can enhance the effects of capecitabine through suppression of NF-?B-regulated markers of proliferation, invasion, angiogenesis, and metastasis.
first_indexed 2025-11-14T07:41:02Z
format Journal Article
id curtin-20.500.11937-21839
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:41:02Z
publishDate 2013
publisher Springer
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-218392018-03-29T09:06:35Z Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products Manu, K. Shanmugam, M. Li, F. Chen, L. Siveen, K. Ahn, K. Kumar, Alan Prem Sethi, G. Simvastatin Apoptosis Chemoresistance Gastric cancer NF-?B Chemoresistance remains a major problem in the treatment of gastric cancer patients. Hence, novel pharmacological agents that can overcome drug resistance are urgently required. Whether simvastatin can sensitize the gastric cancer to the antitumor effects of capecitabine in vitro and in vivo was investigated. The effect of simvastatin on the proliferation of gastric cancer cells was examined by mitochondrial dyeuptake 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method, apoptosis by esterase staining, NF-?B activation by DNA binding assay, and protein expression by western blot analysis. The effect of simvastatin on the tumor growth in xenograft mouse model of human gastric cancer was also examined. Simvastatin suppressed the proliferation of gastric cancer cells, enhanced the apoptotic effects of capecitabine, suppressed the constitutive activation ofNF-?B, and abrogated the expression of cyclooxygenase-2 (COX-2), cyclin D1, Bcl-2, survivin, CXC motif receptor 4, and MMP-9 proteins. In a xenograft mouse model, we observed that the administration of simvastatin alone (5 mg/ kg body weight, intraperitoneal thrice/week) significantly suppressed the growth of the tumor and this effect was further potentiated by capecitabine treatment. As compared to the vehicle control, simvastatin also suppressed the expression of NF-?B-regulated gene products such as cyclin D1, COX- 2, ICAM-1, MMP-9, survivin, Bcl-xL, and XIAP in tumor tissues. Overall, our results demonstrate that simvastatin can enhance the effects of capecitabine through suppression of NF-?B-regulated markers of proliferation, invasion, angiogenesis, and metastasis. 2013 Journal Article http://hdl.handle.net/20.500.11937/21839 10.1007/s00109-013-1095-0 Springer restricted
spellingShingle Simvastatin Apoptosis
Chemoresistance
Gastric cancer
NF-?B
Manu, K.
Shanmugam, M.
Li, F.
Chen, L.
Siveen, K.
Ahn, K.
Kumar, Alan Prem
Sethi, G.
Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
title Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
title_full Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
title_fullStr Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
title_full_unstemmed Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
title_short Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
title_sort simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa b-regulated gene products
topic Simvastatin Apoptosis
Chemoresistance
Gastric cancer
NF-?B
url http://hdl.handle.net/20.500.11937/21839